Delivery Order 36C24423D0013-36C24423N0069
- Not listed
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 4 (VA-VHA VISN 4) has awarded a $856,400 firm fixed-price delivery order to Nuclear Diagnostic Products Of Philadelphia, Inc., doing business as Cherry Hill Pharmacy, a for-profit organization. This delivery order is to provide the radiopharmaceutical product ILLUCCIX (Gallium 68 PSMA-11) to support VA medical imaging programs like PET scans. The delivery order is against a...
- This is a delivery order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 (VA-VHA VISN 4) to Nuclear Diagnostic Products Of Philadelphia, Inc., doing business as Cherry Hill Pharmacy, a for-profit organization. The $1,320,000 firm fixed price delivery order is for the radiopharmaceutical product ILLUCCIX Gallium 68 PSMA-11, which is used for medical imaging and diagnostic procedures. This delivery order is part of a larger...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 (VA-VHA VISN 4) to Nuclear Diagnostic Products Of Philadelphia, Inc., doing business as Cherry Hill Pharmacy, for the supply of the radiopharmaceutical product ILLUCCIX Gallium 68 PSMA-11. The delivery order is valued at $533,260.46 and has an ultimate completion date of May 19, 2017. This order is part of a larger indefinite delivery...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 (VA - VHA) awarded a $462,000.00 purchase order contract to Nuclear Diagnostic Products Of Philadelphia, Inc., doing business as Cherry Hill Pharmacy, for ILLUCCIX Gallium 68 PSMA-11. The prime contractor, a subsidiary of Nuclear Diagnostic Products, Inc., will provide these radiopharmaceuticals from its facility in Philadelphia, Pennsylvania under firm fixed pricing from May 3, 2022 through...
- This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 4 (VA-VHA VISN 4) to Nuclear Diagnostic Products of Philadelphia, Inc., doing business as Cherry Hill Pharmacy. The contract, valued at $126,030.30, is for the provision of ILLUCCIX Gallium 68 PSMA-11, a radiopharmaceutical product used for medical imaging and diagnostic procedures. The contract was awarded as a small business...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a $285,808.53 firm fixed price delivery order to Nuclear Diagnostic Products, Inc. of Cherry Hill, New Jersey for radiopharmaceuticals. The contract has a completion date of March 14, 2022 and was awarded on March 15, 2021 without a set-aside designation. Nuclear Diagnostic Products, Inc. will provide radiopharmaceutical products to support imaging and diagnostic services for...
- Nuclear Diagnostic Products, Inc. was awarded a two-year, firm fixed price delivery order valued at approximately $1.9 million by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA VHA VISN 2) to provide general radiopharmaceuticals. The contract has a period of performance starting February 22, 2021 through February 21, 2023, with all work to be conducted by the prime contractor at its facility located in Rockaway, New Jersey. No major...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 (VA-VHA) awarded a $512,979.57 firm fixed price delivery order contract to Nuclear Diagnostic Products, Inc. of Lebanon, Pennsylvania to provide radiopharmaceuticals. The contract, which runs from March 15, 2022 through March 14, 2023, will support the VA-VHA's medical imaging needs through the delivery of radiopharmaceuticals, which are radioactive compounds used in medical imaging...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization located in Rockaway, New Jersey. The contract, valued at $909,914.80, is for the supply of general radiopharmaceuticals to support nuclear medicine diagnostic procedures at VA medical facilities within the VA's Veterans Integrated Service Network 2 (VISN 2), which covers the northeastern United States. The contract is a modification...
- This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit company specializing in the supply of radiopharmaceuticals for the VA healthcare system. The $111,392.95 delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $4,038,178.15 with the VA's Veterans Integrated Service Network (VISN) 2 for general radiopharmaceuticals, with a performance period through February 2026. The contract does not...
- 36C24423D0013Indefinite Delivery Contract
- 36C24423D0013-36C24423N0069Delivery Order
Nuclear Diagnostic Products of Philadelphia, Inc., doing business as Cherry Hill Pharmacy, has been awarded delivery order contracts totaling over $9.3 million by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 (VA-VHA VISN 4) to supply the radiopharmaceutical product ILLUCCIX Gallium 68 PSMA-11. The contracts have no set-aside designation. Cherry Hill Pharmacy holds a single-award Indefinite Delivery Contract from VA-VHA VISN 4 with a potential value of $9.345 million over five years to provide ILLUCCIX. Two delivery orders have been issued against this contract so far, including the initial $5 million delivery order awarded November 4, 2022 for fulfillment through November 3, 2027 out of Cherry Hill Pharmacy's Philadelphia, Pennsylvania facility. A subsequent $1.176 million delivery order was awarded November 4, 2023 for the same product and period of performance. Both utilize firm fixed pricing. ILLUCCIX supports nuclear medicine imaging procedures for veterans within the VA-VHA VISN 4 region. Nuclear Diagnostic Products, Inc. is the prime contractor's parent company and provides additional radiopharmaceuticals to VA medical centers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($630k) | 3/8/24 | |
| Not listed | Not listed | $997.5k | 10/3/22 |